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-Synuclein is thought to regulate neurotransmitter release through multiple interactions with presynaptic proteins, cytoskeletal ele-
ments, ion channels, and synaptic vesicles membrane. -Synuclein is abundant in the presynaptic compartment, and its release from
neurons and glia has been described as responsible for spreading of-synuclein-derived pathology.-Synuclein-dependent dysregula-
tion of neurotransmitter release might occur via its action on surface-exposed calcium channels. Here, we provide electrophysiological
and biochemical evidence to show that -synuclein, applied to rat neurons in culture or striatal slices, selectively activates Cav2.2
channels, and said activation correlates with increased neurotransmitter release. Furthermore, in vivo perfusion of-synuclein into the
striatum also leads to acute dopamine release. We further demonstrate that -synuclein reduces the amount of plasma membrane
cholesterol and alters the partitioning of Cav2.2 channels, which move from raft to cholesterol-poor areas of the plasmamembrane. We
provide evidence for a novel mechanism through which -synuclein acts from the extracellular milieu to modulate neurotransmitter
release and propose a unifying hypothesis for the mechanism of -synuclein action on multiple targets: the reorganization of plasma
membrane microdomains.
Key words: Cav2.2 channels; dopamine release; extracellular alpha-synuclein; lipid rafts
Introduction
-Synuclein (Syn), an unfolded soluble cytosolic protein, has
been reported to accumulate in Lewy bodies, which are intraneu-
ronal aggregates pathognomonic of Parkinson’s disease (PD)
(Spillantini et al., 1997). Although the aggregation pathways and
the toxicity of aggregated forms of Syn have been studied exten-
sively, little is known about the role ofmonomeric Syn in the early
phases of PD. Syn is highly enriched in presynaptic terminals, but
a substantial fraction of this protein is released in extracellular
fluids in healthy and PD subjects (Borghi et al., 2000; El-Agnaf et
al., 2003). Importantly, healthy dopaminergic grafts implanted in
the striatum undergo degeneration accompanied by Syn-
containing Lewy bodies (Kordower et al., 2008a,b), suggesting a
potential role of secreted extracellular Syn in the onset of the
disorder. Although the direct transfer of Syn between neurons
has been demonstrated (Hansen et al., 2011; Volpicelli-Daley et
al., 2011), little is currently known about the process of release of
Syn and its physiopathological function. Duplications and tripli-
cations of the SNCA gene encoding -synuclein are present in
familial forms of PD. Recently, the SNCA gene was identified as a
risk locus in genome-wide association studies for PD, highlight-
ing the importance of wild-type Syn levels as pathogenic factor
also in the sporadic form of PD (Satake et al., 2009; Venda et al.,
2010).
Maintenance of calcium homeostasis through the regulation
of presynaptic calcium channels and intracellular calcium stores
is fundamental for correct synaptic activity. Calcium dyshomeo-
stasis has been proposed recently as the primary age-related con-
dition driving neurodegeneration in the sporadic form of PD, in
which selective subpopulations of neurons undergo degenera-
tion. Dopaminergic neurons expressing higher levels of calcium
binding proteins, such as calbindin, calretinin, and parvalbumin,
seem to be resistant to degeneration in PD (Damier et al., 1999;
Kim et al., 2000; Soo´s et al., 2004). Dysfunction in the ion chan-
nels and receptors regulating synaptic communication may con-
tribute to the cognitive decline, neurological and motor
symptoms associated with chronic disorders (Walsh and Selkoe,
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2004; Mattson, 2007). In neurons, presynaptic voltage-gated cal-
cium channels (Cav) 2.1 and Cav2.2 are predominantly responsi-
ble for coupling neuronal depolarization to neurotransmitter
release. In particular, Cav2.2 underlie dopamine (DA) release in
the basal ganglia (Bergquist et al., 1998). In SH-SY5Y cells, an
increase in calcium influx through Cav has been suggested to be
caused by increased expression of Syn or by extracellular Syn
(Hettiarachchi et al., 2009; Melachroinou et al., 2013). In synap-
toneurosomes, an increase in calcium influx through Cav2.2 oc-
curs during incubation with micromolar Syn concentrations;
such an effect occurred independently of free radical generation
and was suggested to arise through a direct interaction of Syn
with Cav2.2 (Adamczyk and Strosznajder, 2006). Mouse models
of Syn-induced neurodegeneration exhibit a decreased DA re-
lease, similar to that observed in PD patients (Decressac et al.,
2012; Lundblad et al., 2012; Nuber et al., 2013). However, in-
creased tonicDA levels attributable to early synaptic dysfunction,
preceding the death of dopaminergic neurons and leading to a
possible disruption of corticostriatal transmission (Wu et al.,
2010), were found in Syn transgenic mice at a young age (Lam et
al., 2011), similar to that assessed in other PD models (Goldberg
et al., 2003).
Here we evaluate the alteration of synaptic activity attribut-
able to the presence of raised concentrations of Syn in the extra-
cellular space. We analyze in detail the effect of extracellularly
applied monomeric Syn on depolarization-evoked calcium in-
flux and Cav2.2 calcium current density in neurons and on neu-
rotransmitter release in vitro and in vivo, identifying the
molecular mechanism of Syn action as a decrease in raft parti-
tioning of Cav2.2 to induce DA release. Such a Syn regulatory
mechanismmay have important consequences in PD and related
synucleopathies.
Materials andMethods
Reagents
All chemicals, unless otherwise stated were purchased from Sigma-
Aldrich. The following primary antibodies were used: anti-Cav2.2
1B (A-11; Santa Cruz Biotechnology catalog #sc-271010, RRID:
AB_10611357), anti-G-protein 1 (C-16; Santa Cruz Biotechnology cat-
alog #sc-379, RRID:AB_2111823), anti-21 subunit (Santa Cruz
Biotechnology catalog #sc-133436, RRID:AB_10609764), anti-Hsp90
(Santa Cruz Biotechnology catalog #sc-59578, RRID:AB_2295578), anti-
flotillin-1 (BDBiosciences catalog#610821,RRID:AB_398140), anti-caveolin-1
(BD Biosciences catalog #610059, RRID:AB_397471), anti--synuclein (BD
Biosciences catalog #610787, RRID:AB_398108), anti-Na/KATPase (EMD
Millipore catalog #05-369, RRID:AB_309699), anti-Cav-2 subunit
(Sigma-Aldrich catalog #C5738, RRID:AB_258910), anti-synaptophysin
(Synaptic Systems catalog #101 011, RRID:AB_887824), anti-syntaxin
1A antibody (Santa Cruz Biotechnology catalog #sc-58299, RRID:
AB_785887), anti-Rab11 (Life Technologies catalog #700184, RRID:
AB_10562415), and anti-Cav1.2 (Hell et al., 1996). Syn peptides (amino
acids 12–23, 34–45, and 61–78) were obtained from Primmbiotech.
Rat primary cortical cultures
All experiments were performed in accordance with the Italian Ministry
of Health. Primary cultures of rat embryonic cortical neurons were pre-
pared as described previously (Brewer, 1997). Briefly, E18 Sprague Daw-
ley rat embryos (Charles River) were decapitated, and cortices were
rapidly dissected and dissociated by incubation in Neurobasal medium
(Life Technologies) containing 20 U/ml papain, 1.1 mg/ml cysteine, and
125 g/ml DNase for 30 min at 37°C. After cell dissociation, cortical
neurons were plated in either six-well dishes at a density of 1  106
cells/ml on glass coverslips coated with poly-L-lysine (0.1 g/ml) or 100
mm Petri dishes coated with poly-L-lysine (0.01 g/ml) at a density of
5  106 cells per dish. Cells were cultured in Neurobasal medium sup-
plemented with B-27, GlutaMAX, and penicillin–streptomycin (all from
Life Technologies) and maintained at 37°C in 5% CO2. In all experi-
ments, neurons were used between 7 and 14 d in vitro (DIV).
Syn purification
The construct encoding the full-length human wild-type Syn inserted in
the pET21d plasmid was a kind gift from Dr. B. Lauring (Columbia
University, New York, NY). Purification was performed as described
previously (Martinez et al., 2003). Bacteria were induced during the ex-
ponential phase with 1 mM isopropyl -D-1-thiogalactopyranoside for
2 h and harvested by centrifugation. The pellet was solubilized in 20 mM
HEPES/KOH, pH 7.2, and 100 mM KCl (buffer A) and heated for 5 min
at 90°C. The cell lysate was centrifuged at 72,000 g for 30 min, and the
supernatant was loaded on a HiTrap monoQ column (GE Healthcare).
Syn was eluted with a liner gradient of KCl from 100 to 500 mM, and the
fractions of interest were concentrated using a Centricon centrifugal fil-
ter (Millipore) before loading on a Superose 12 column in buffer A (GE
Healthcare). The fractions containing Syn were pooled, concentrated,
and stored at 80°C. To control Syn purity, 1 mg of purified Syn was
loaded on top of a Superdex 75 10/300 column (GE Healthcare) and
eluted at 0.5 ml/min on an AKTA Purifier apparatus. Optical density
(OD) was continuously measured at 280 nm.
Lipid raft isolation
All procedures were performed at 4°C. Lipid raft isolationwas performed
on cortical neurons at 10 DIV as described previously (Butchbach et al.,
2004). Briefly, primary cortical neurons (5 106 neurons per dish) were
incubated for 1 h at 4°C with 80 l/dish PBS containing 1% of Triton
X-100 and Complete Mini protease inhibitor (Roche Applied Science).
The extract was added with sucrose to obtain a 40% final concentration.
A total of 900 l of the extract was placed on the bottom of an ultracen-
trifugation tube, and a discontinuous 5–30% sucrose gradient was
formed on top of the extract. The gradient was then centrifuged at 47,000
rpm for 16 h at 4°C using aMLS 50 rotor (Beckman Coulter). Ten 0.5 ml
fractions were collected from the top of each gradient. A total of 400l of
the samplewas added to 100l of 5 SDS-PAGE loading buffer (100mM
Tris, pH 7.5, 7.5 mM EDTA, 10% SDS, 10% -mercaptoethanol, 50%
glycerol, and 0.02% bromophenol blue).
Biotinylation procedure
The entire biotinylation procedure was performed at 4°C. Labeling of
proteins of the plasma membrane was achieved by biotinylation of cor-
tical neurons (10 DIV) and was a slight modification of the protocol
reported previously (Butchbach et al., 2004). The cells were washed twice
in PBS and once in HBSS and then incubated in HBSS containing 0.6
mg/ml EZ-link Sulfo-NHS-biotin (Thermo Fisher Scientific) for 15min.
The cells were then incubated in quenching buffer (5%BSA inHBSS) for
10 min, scraped, and recovered by centrifugation. Cell pellets were incu-
bated for 1 h with constant shaking in PBS containing 1% Triton X-100
and Complete Mini protease inhibitor (Roche Applied Science). The
biotinylated extract was separated in a sucrose gradient (as described
above), the fractionwas collected, and SDSwas added to a final 0.5%.The
biotinylated proteins present in each fraction were pulled down by incu-
bation with 100 l of Neutravidin beads (50% slurry; Thermo Fisher
Scientific) for 2 h. Avidin beads were then recovered by centrifugation
andwashed four times in PBS. Afterwashing, boundproteinswere eluted
with 1 SDS-PAGE loading buffer (20 mM Tris, pH 7.5, 1.5 mM EDTA,
2% SDS, 2% -mercaptoethanol, 10% glycerol, and 0.004% bromophe-
nol blue).
Immunoblot analysis
SDS-PAGE and electrotransfer of membranes were performed as de-
scribed previously (Laemmli, 1970). Immunoreactive bands were de-
tected by chemiluminescence, and images were acquired using an LAS
AF 4000 apparatus (GEHealthcare). Bands intensities were measured by
Image Quant analysis software (GE Healthcare).
Filipin quantitative staining
Filipin quantitative staining of fixed cells was performed accordingly to a
modification of a commercially available kit (catalog #10009779; Cay-
man Chemicals). Briefly, cortical neurons (10 DIV) plated on 18 mm
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coverslips were fixed with 4% (v/v) PFA, washed in PBS, and incubated
for 1 h in PBS containing 1% Triton X-100 (filipin total staining) or PBS
(filipin membrane staining). Next, coverslips were incubated for 1 h at
room temperature in 30 l of PBS and 10%NGS (Thermo Fisher Scien-
tific), containing 100 g/ml filipin [freshly prepared from a 10 mg/ml
stock solution (in EtOH) stored at 20°C]. Finally, coverslips were in-
cubated for 30 min at room temperature in 500 l of 1% SDS, and the
fluorescence of the solution was measured on a LS55 fluorometer
(PerkinElmer Life and Analytical Sciences).
Fluo-4 imaging
Rat embryonic cortical neurons were plated onto 25 mm coverslips at a
density of 800 neurons/mm2 and at 6–10 DIV were incubated with buf-
fer A or 5 M Syn for 2 h at 37°C. Neurons were then loaded with
Fluo-4-AM (2.5 M; Life Technologies) for 20 min at 37°C. Coverslip
were then transferred into a perfusion chamber (Warner Instruments)
and superfused with modified Krebs’ solution containing the following
(in mM): 135 NaCl, 5 KCl, 1.5 CaCl2, 0.75 MgCl2, 0.75 KH2PO4, 1.5
MgSO4, 5.6 glucose, and 20 Na-HEPES, pH 7.4 (adjusted with NaOH).
NBQX at 10M, 50M D-APV, and 100M picrotoxin were added to the
solution. Nifedipine at 10 M, 300 nM -conotoxin GVIA, or 100 nM
-agatoxin IVA (Bachem) was added as described. Fluo-4 fluorescence
was recorded at 494 10 nm wavelength at 1 Hz for 3 min. Basal fluo-
rescence was recorded for 1 min, and then Ca2 entry was elicited by a
60 s bath application of amodifiedKrebs’ solution containing 50mMKCl
with a reciprocal decrease in Na concentration. A single stimulation
was performed per coverslip. Results were expressed as the ratio between
the basal fluorescence and the maximum fluorescence of the neurons
during 50mMKCl stimulation (F/F0). F/F0 ratio was normalized for each
experiment to the respective control. Calcium imagingwas performedon
a Leica AF6000 microscope to acquire images at 1 frame/s.
GCaMP3 imaging
Rat embryonic cortical neurons were plated at a density of 400 neurons/
mm2 and at 10 DIV were transfected with SyGCaMP3 (GCaMP3 with
synaptophysin; Niwa et al., 1991; kindly provided by Dr. Susan Vogl-
maier, University of California, San Francisco, San Francisco, CA) using
calcium phosphate. At 13 DIV, cells were treated with buffer A or 5 M
Syn for 2 h at 37°C. Imaging was performed as described above using the
same acquisition and stimulation conditions. Data were analyzed with
the NIH ImageJ plugin Time Series analyzer 2.0. After subtraction of the
first image from the image obtained during the peak of stimulation with
50 mM KCl and application of a threshold to obtain a binary image,
boutons were identified using theNIH ImageJ Analyze Particles software
to detect regions of interest (ROIs).
Electrophysiology
Superior cervical ganglia neurons for patch-clamp recordings. Superior cer-
vical ganglia neurons (SCGNs) were acutely dissected from 3- to 6-week-
old male Wistar rats according to the guidance of the UK Animals
(Scientific Procedures) Act 1986 subject to University of Reading Local
Ethic Research Panel review, as described previously (Bucci et al., 2011).
Briefly, SCG were dissected and placed in cold L-15 medium (Sigma
Aldrich) containing 5% penicillin–streptomycin (Life Technologies).
The ganglia were then acutely dissociated in DMEM containing 0.5
mg/ml trypsin, 1 mg/ml collagenase, and 3.6 mg/ml glucose (all from
Sigma Aldrich). After incubation at 37°C for 30–40 min, the digestion
reaction was stopped by the addition of 84% Eagle’sMEM, 10% fetal calf
serum, 5%horse serum (Lonza), and 1%penicillin–streptomycin (Gibco
Invitrogen). After dissociation, cells were plated onto coverslips coated
with poly-L-ornithine (Sigma-Aldrich) and incubated at 37°C (5% CO2)
before electrophysiological recordings.
Whole-cell voltage-clamp recordings. Whole-cell recordings from iso-
lated SCGNs were performed as described previously (Bucci et al., 2011)
using borosilicate glass electrodes with resistances between 5 and 7 M
when filled with an intracellular solution [in mM: 140 CsCl, 10 HEPES,
0.1 CaCl2, 1.0 MgCl2, 4 Mg-ATP, 0.2 Na-GTP, and 1.0 EGTA, pH 7.3
(adjusted with CsOH)] and an extracellular solution [in mM: 160 tetra-
ethylammonium bromide, 10 HEPES, 3 KCl, 1 MgCl2, and 4 glucose,
with 10 mM Ba2 as charge carrier, pH 7.4 (adjusted with Sigma 7–9
base)]. Membrane currents were acquired at a holding potential (Vh) of
70 mV using an Axopatch 200B patch-clamp amplifier and WinWCP
version 4.0.7 software (John Dempster, University of Strathclyde, Glas-
gow, UK). Linear components of capacitive and leak currents were sub-
tracted using the standard P/4 protocol. Series resistance compensation
of70% was typically used. Data were analyzed offline using WinWCP
version 4.0.7, OriginPro version 7.0 (Microcal), and MATLAB (Math-
Works) software. I–V data were fitted with the modified Boltzmann
equation:
current density: Gmax(V Vrev)/(1 exp(V V0.5)/k)),
where Gmax is the maximum conductance, Vrev is the null potential, V0.5
is the voltage at which 50% of the current is activated, and k is the slope
factor. To determine V0.5 and k values accurately, data from normalized
tail current amplitude was fitted with a standard Boltzmann function.
Statistical significance (taken as p 0.05) was determined using one-way
ANOVA, Student’s t test, or Mann–Whitney U test, as indicated.
Synaptic transmission between SCGNs. Cells were prepared as de-
scribed previously (Mochida et al., 1996). Briefly, males Wistar rats were
decapitated on postnatal day 7 under diethylether anesthesia according
to the guidelines of the Physiological Society of Japan. SCGNs were iso-
lated and maintained in culture for 6–7 weeks in a growth medium of
84%Eagle’sMEM, 10% fetal calf serum, 5% horse serum, 1% penicillin–
streptomycin (all from Life Technologies), and 25 ng/ml nerve growth
factor (2.5 S, grade II; Alomone Labs).
Paired intracellular recordings weremade from two proximal neurons
using microelectrodes filled with 1 M potassium acetate (70–90 M) as
described previously (Mochida et al., 2003). Briefly, SCGNs were super-
fused with modified Krebs’ solution containing the following (in mM):
136 NaCl, 5.9 KCl, 2.5 CaCl2, 1.2 MgCl2, 11 glucose, and 3 Na-HEPES,
pH 7.4 (adjusted withNaOH). Action potentials (APs) were generated in
a neuron by current injection (at 0.1 Hz) through the intracellular re-
cording electrode and EPSPs recorded from the synaptically coupled
neuron. Data were analyzed using software written by the late Ladislav
Tauc (National Center of Scientific Research, Paris, France). Through-
out, data were obtained at 32–35°C. Collected data were analyzed with
Origin software (Origin Lab) and are reported as means SEMs. Statis-
tical significance (taken as p  0.05) was determined using Student’s t
test.
Fast-scan cyclic voltammetry
Male Wistar rats were anesthetized with halothane and decapitated. The
brain was removed, and coronal slices containing the dorsal striatum
were cut at a thickness of 300 m in cold carboxygenated artificial CSF
(aCSF; in mM: 125 NaCl, 2.5 KCl, 0.3 KH2PO4, 26 NaHCO3, 2.4 CaCl2,
1.3 MgSO4, and 10 D-glucose) using a VT1000S vibrating microtome
(LeicaMicrosystems). Dorsal striatal brain slices were allowed to recover
for at least 1 h at room temperature in carboxygenated aCSF. For record-
ings, slices were superfusedwith 32°C carboxygenated aCSF at a flow rate
of 1ml/min. Experimental recordings started aminimumof 20min after
transfer to the slice chamber. Carbon fiber electrodes (5 m; Goodfel-
low) were made as described previously (Kuhr and Wightman, 1986).
Electrodes were inserted 	100 m into the slice. The potential of the
working electrode was held at0.4 V versus Ag/AgCl between scans and
was ramped to1.3 V at 300 V/s and back at0.4 V every 100ms via an
A-M Systems isolated pulse stimulator. The triangular waveform was
computer controlled using a HEKA EVA8 potensiostat and a ESA Bio-
science fast-scan cyclic voltammetry interface analog-to-digital con-
verter via TH-1 software (ESA Biosciences). Axonal DA release in the
dorsolateral striatum was evoked using a twisted bipolar stimulating
electrode (Plastics One). Stimulations were delivered every 2 min by a
single electrical pulse (1ms, 400A). Syn at 5M (dissolved in aCSF)was
superfused 10min after the first measure. For-conotoxin experiments,
drug was superfused (at 1 ml/min) starting from 4 min before the first
recording until the end of the experiment. Background-subtracted cyclic
voltammograms were obtained by subtracting the current obtained be-
fore stimulation from all recordings. The peak oxidation current for DA
in each voltammogram was converted into a measure of DA concentra-
tion by post-calibration of the electrode using 1MDA (Sigma-Aldrich).
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Datawere normalized to the first five recordings (10min) of their respec-
tive control period and plotted against time (means SEMs). Statistical
significance (taken as p  0.05) was determined by two-way ANOVA
(time treatment as variables).
Microdialysis
In vitro Syn microdialysis was performed to verify Syn diffusion through
the microdialysis membrane. A 4 mm, 100 kDa cutoff membrane
(CMA12 guide; CMA Microdialysis) was connected to a microdialysis
syringe pump (CMA-402 syringe pump; CMA Microdialysis). aCSF (in
mM: 147 NaCl, 2.7 KCl, 1.2 CaCl2, and 0.8 MgCl2) plus 10 M Syn was
used as a perfusionmedium at a flow rate of 0.1l/min. Themicrodialy-
sis cannula was immersed in 50l of aCSF, and the appearance of Syn in
the solution was measured by SDS-PAGE and Western blot performed
on 2 l fractions sampled at the indicated times.
In vivo Syn microdialysis was performed in awake and freely moving
rats (males Wistar). A guide cannula (CMA12 guide; CMA Microdialy-
sis) was stereotaxically implanted in the right striatum under isoflurane
anesthesia and cemented. Stereotaxic coordinates for probe positioning
were chosen according to a rat brain atlas: anteroposterior, 1.0 mm;
lateral, 3.0 mm; and dorsoventral,6.5mm relative to bregma. Approx-
imately 24 h after surgery, dialysis probes were inserted into the guide
cannula. The dialysis probes were perfused during implantation into the
brain and for 1 h afterward with aCSF. At 1 h after the operation, animals
were returned to their home cages. On the next day, the dialysis probes
were connected to a syringe pump and perfused with aCSF at 1.0l/min
for 30 min (washout period). After this stage, the perfusion rate was
changed to 0.25 l/min, and aCSF was perfused for 2 h (equilibration
period). The solutionwas then changed to aCSF containing buffer A, and
perfusion was continued for 3 h at 0.25 l/min. Samples were collected
every 60 min into collection tubes containing 2 l of perchloric acid (1
M). After the experiment, animals were disconnected from the system
and were left in their home cage overnight. On the second day, the dial-
ysis probeswere connected again to a syringe pump and perfused accord-
ing to the protocol described abovewith addition of aCSF containing Syn
(10 M). The samples collected during hour 3 of Syn or buffer A appli-
cation were used for analysis. DA content in samples collected with and
without Syn application was determined by HPLC.
HPLC analytical procedure
Measurements of DA in microdialysis samples were performed using
HPLC with electrochemical detection (ALEXYS LC-EC system)
equipped with a reverse-phase column (3 m particles, ALB-215 C18,
1 150 mm; Antec) at a flow rate of 200 l/min and electrochemically
detected by a 0.7 mm glass carbon electrode (VT-03; Antec). The mobile
phase contained 50 mM H3PO4, 50 mM citric acid, 8 mM KCl, 0.1 mM
EDTA, 400 mg/l octanesulfonic acid sodium salt, and 10% (v/v) metha-
nol, pH 3.9. The sensitivity of the method allowed detection of	3 fmol
of DA. Dialysate samples (11 l) were injected into HPLC without any
additional purification.
Results
Extracellular Syn induces an increase in evoked calcium entry
through Cav2.2
Syn has been shown to be released in physiological and patholog-
ical conditions in vitro and in vivo. First, we confirmed the release
of Syn from cultured rat neurons over a period of 48 h; Syn was
found in the medium in picomolar concentration. Neurons
showed no sign of damage or leakage of cytosolic proteins as
shown by the absence of GAPDH in the media (Fig. 1A). To
determine whether extracellular Syn can affect intracellular cal-
cium levels, we applied highly purified Syn to rat cortical neurons
(10 DIV). The monomeric state of purified Syn was assessed by
gel filtration and SDS-PAGE (Fig. 1B). During incubation of the
purified protein with cultured neurons, the formation of oligom-
ers was found at 48 h (Fig. 1C). The absence of oligomeric or
cleaved products of the protein after 2 h incubation was con-
firmed by gel filtration. Fractions collected from the column
showed that the bulk of Syn elutedwith proteins of 14–20 kDa, as
assessed by a calibration column, and indicate that Syn was mo-
nomeric (Fig. 1D). Neurons were incubated with or without re-
combinant Syn (5 M) for 2 h at 37°C and subsequently loaded
with the calcium dye Fluo-4 (Fig. 2A). In the presence of AMPA
and NMDA ionotropic glutamate receptor blockers, we did not
detect any significant effect on basal calcium level during Syn
application, whereas we measured an	12% increase in calcium
influx after depolarization of neurons with 50 mM KCl (Fig. 2A,
middle). We evaluated the time course of effects of Syn preincu-
bation and found a significant increase in calcium influx after 30
min, which was higher and more reproducible after 2 h preincu-
bation (Fig. 2A, right).We applied nifedipine (10M), a selective
blocker of Cav1, to analyze their possible involvement in Syn
action. Under these conditions, we found a significantly larger,
(	22%) increase in calcium signal during Syn exposure, suggest-
ing that, in the absence of nifedipine, we could have underesti-
mated the change in fluorescence because of partial dye
saturation (Fig. 2B, left). To determine which calcium channels
are targeted by Syn,we used, in addition to nifedipine, the specific
calcium channel inhibitors -agatoxin IVA and -conotoxin
GVIA to block Cav2.1 and Cav2.2, respectively (Fig. 2B, middle
and right). -Agatoxin had no effect on Syn-induced increase in
calcium entry, whereas -conotoxin completely abolished the
effect of Syn, indicating that Cav2.2 are selectively affected by Syn
in cortical neurons. Because of the power relationship between
calcium influx and exocytosis (Dodge and Rahamimoff, 1967),
small changes in influxmight have profound effects on transmit-
ter release; however, to exclude the possibility that the effect of
Syn could be unspecific, we used three distinct Syn peptides: (1)
P34 (amino acids 34–45), i.e., the glycosphingolipid-binding do-
main of Syn; (2) P61 (amino acids 61–78), i.e., the cholesterol
Figure1. Analysis of released Syn andpurified Syn incubatedwithneurons.A, Immunoblots
showing the presence of Syn in the culturemedia collected from rat cortical neurons at 6, 8, and
10 DIV over a 48 h period, and, in the homogenate (hom) collected at 10 DIV, GADPHwas used
as a control for membrane leakage. The amount of Syn in the media is in the picomolar range
(quantified by densitometry compared with a standard curve of purified Syn). B, Left, FPLC
chromatogram of recombinant Syn. OD measured at 280 nm of purified Syn (1 mg) loaded on
top of a Superdex 75 10/300 column and eluted a 1 ml/min. Right, Syn (10g) was loaded on
13%acrylamidegel and subjected to Coomassie staining (left; rainbowmolecularweightmark-
ers are indicated) or immunoblotted with anti-Syn antibody. C, Immunoblot of the medium
collected from 10 DIV rat cortical neurons incubated with recombinant Syn for 0.1, 6, and 48 h,
showing thepresenceof SDS-resistant higher-molecular-weight Synproducts (oligomers) after
48 h. D, Immunoblot of the fractions eluted at 0.5 ml/min from a Superdex 75 10/300 column
loadedwith themediumcollected from10DIV rat cortical neurons incubatedwith recombinant
Syn for 2 h. The elution peak of BSA (67 kDa), ovalbumin (43 kDa), ribonuclease A (13.7 kDa),
and aprotinin (6.5 kDa), separated under the same conditions, is indicated by each of the
arrows.
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binding domain of Syn that has been shown to inducemembrane
leakage and to aggregate (Crowet et al., 2007; Fantini et al., 2011);
and (3) P12 (amino acids 12–23), a peptide with no recognized
function. None of these peptides determined measurable effects
on calcium entry (Fig. 2C), indicating that the whole protein,
albeit unfolded, is required for its activity on Cav2.2.
Cav2.2 are localized presynaptically and are major regulators
of neurotransmitter release (Westenbroek et al., 1992; Catterall,
2000; Garner et al., 2000). To investigate the action of extracellu-
lar Syn on calcium influx specifically in the presynaptic compart-
ment, the calcium indicator GCaMP3 was targeted to synaptic
vesicles as a chimera with the synaptic vesicle associated protein
synaptophysin (SyGCaMP3) (Li et al., 2011). In neurons express-
ing SyGCaMP3, the fluorescent signal in presynaptic boutonswas
increased during KCl perfusion (Fig. 2D). In the selected ROI,
fluorescence reached a peak lasting	7 s (Fig. 2E). Incubation of
neurons with Syn induced an 	15% increase in calcium entry
at the presynapse that was also completely abrogated by
-conotoxin (Fig. 2F), suggesting a possible activity of extracel-
lular Syn in the regulation of neurotransmitter release by Cav2.2.
Extracellular Syn increases whole-cell Cav2.2 current density
and synaptic transmission in isolated SCGNs
Rat SCGNswere used tomeasure the Syn effect onCav2.2 activity
because, in these neurons, 85% of calcium current is carried by
-conotoxin-sensitive Cav2.2 (Stoehr et al., 1997). Whole-cell
calcium currents (measured as IBa) in SCGNs cultured 1–2 dwere
assessed after 2 h preincubationwith purified recombinant Syn at
various concentrations (Fig. 3A, representative traces in center
panel). The modulatory effect of Syn was measured against sep-
arate pools of internal control recordings from SCGNswithin the
same preparation. Pretreatment of neurons with 5 M Syn in the
culture medium caused an 	70% increase in calcium current
density at 0 mV and a corresponding increase in Gmax (Fig. 3A;
Table 1). In these experiments, control Syn had no significant
effect on Vrev (Table 1). At a 10 times lower concentration (0.5
M), Syn also produced a significant increase of calcium current
density and Gmax with no significant difference between the two
concentrations tested, whereas 0.1M Syn, the lowest concentra-
tion applied, failed to produce any significant effect compared
with controls (Fig. 3A, right; Table 1). To investigate the effect of
Syn onV0.5 and slope factor (k), we fitted Boltzmann functions to
tail current amplitude data measured at 120 mV; these proto-
cols use short activation pulses to avoid any contaminating
voltage-dependent current inactivation and so give the most ac-
curate measures of transition between closed and open states.
Concentrations of Syn that affected current density andGmax had
no effect on V0.5, but caused a significant decrease in k values
(Table 2). The reduction in k suggests that Syn improves the
movement of gating charges and, thus, facilitates transition from
a closed to open state that occurred over a smaller voltage range in
Syn-modified channels. In addition, Syn had no effect on steady-
state inactivation V0.5 and slope factor k (see Fig. 5D); these data
Figure 2. Extracellular Syn increases calcium influx through Cav2.2. A, Left, Representative
trace of a calcium transient of a cortical neuron obtained after perfusion for 60 s with 50mM KCl
(starting point at 60 s). Neurons were incubated with 5 M Syn (red dots) for 2 h at 37°C or
without (black dots); neurons were loaded with Fluo-4 and imaged at 1 frame/s. Data are
expressed as F/F0 (ratio between basal fluorescence in the first 20 s and fluorescence at each
data point). Middle, Bar chart showing the increase in fluorescence calculated at the point of
maximum value in Syn-treated neurons (red; n
 150). Data were pooled from different ex-
periments and normalized to the respective control (black; n
 150) in each experiment. Right,
Bar chart showing the increase in fluorescence, calculated as above, in neurons treated with 5
M Syn for 20 min, 2 h, and 4 h (red; n
 83, n
 63, n
 67). Data were normalized to the
control (black; n
 120) in each experiment. Statistical significance determined by one-way
ANOVA. *p 0.05. B, Quantification of Fluo-4 fluorescence during KCl depolarization in Syn-
treated neurons (red), calculated as above, in the presence of 10M nifedipine (nife; n
 600),
100 nM-agatoxin (aga; n
 450), or 300 nM-conotoxin (cono; n
 250), each bath applied
3 min before KCl perfusion. Data are expressed as mean  SEM of F/F0 normalized to the
respective control (black; same n as Syn-treated samples). C, Bar chart showing the increase in
fluorescence calculated as above, in neurons treatedwith 5M P12, P34, and P61 Syn peptides
for 2 h (red; n
 150, n
 375, n
 167). Data were pooled from different experiments and
normalized to the respective control (black;n
150,n
376,n
100) in each experiment.D,
Series of microphotographs showing a group of positive synapses (black arrow) in neurons
transfectedwith SyGCaMP3anddepolarizedwith 50mMKCl in the presence of nifedipine and in
the absence (top) or presence (bottom)of Syn. KClwasperfused starting at frame12and caused
4
synaptic boutons to emit fluorescence immediately. ctrl, Control. E, Representative trace of the
increase in calcium in neurons transfected with SyGCaMP3 and depolarized as above. Neurons
were incubatedwith 5M Syn (red dots) or without (black dots) as in A. Images were acquired
at 1 frame/s.F, Left, Quantificationof the fluorescence in SyGCaMP3-positive boutons (red;n

100) in Syn-treated neurons normalized to the respective control (black; n 
 100). Right,
Quantification as in the left panel of neurons perfused with 300 nM-conotoxin (cono) 3 min
before KCl. Data were expressed as the mean  SEM of F/F0 normalized to the respective
control. Statistical significance in A–C and F determined by nonparametric t test. *p 0.05.
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rule out any Syn-induced shift in voltage inactivation as the
mechanism underlying the observed increase in calcium current
density. The possibility that enhanced currents induced by Syn
were attributable to an increase in the membrane surface of
SCGNs was ruled out by capacitance measurement that revealed
no changes between control and Syn-treated SCGNs with differ-
ent current densities (Fig. 3B).
Calcium channels in SCGNs are physiologicallymodulated by
voltage-dependent G-proteins (Dolphin, 1996), and G-protein
modulation is characterized by an inhibition of current ampli-
tude (Stephens et al., 1998). Therefore, we examined the effect
of Syn on endogenous G-protein modulation. Transient dissoci-
ation of G-proteins from the channel induces facilitation of cal-
cium currents that can be measured in response to a brief,
strongly depolarizing voltage step [named prepulse facilitation
(PPF)]. A prepulse of120mVwas applied to control neurons to
measure endogenous G-protein modulation (Fig. 3C; Table 3).
In the control group (Fig. 3C, left; Table 3), the ratio between the
currents recorded before (P1) and after (P2) the PPF step was
1.43 0.10 (n
 10) at 0 mV. After pretreatment with 5 M Syn
(Fig. 3C, right; Table 3), the P2/P1 ratio was 1.31 0.11 (n
 10)
Figure 3. Extracellular Syn increases IBa currents and synaptic transmission in SCGNs. A, Left, Mean calcium current density–voltage relationships for control (black circles; n
 8) and 5M
Syn-treated (red circles; n
 10) SCGNs. Continuous lines are modified Boltzmann fits to each current density–voltage curve. Currents were evoked using 50 ms depolarizing test pulses in 10 mV
intervals from a Vh of70mV. Data are shown asmean SEM.Middle, Superimposed representative traces showing currents at 0mV in control (black) and after treatment with 5M Syn for 2 h
(red). Right, Bar graph summarizing the effect of Syn on IBa and showing data for 0.1M Syn (light pink; n
 5), 0.5M (dark pink; n
 6), 5M (red; n
 10), and the respective controls (black;
n
6,n
6,n
8, respectively). Statistical significancedeterminedbynonparametric t test. *p0.05.B, Plot of capacitanceversus current at 0mVrecorded inSCGNs incubatedwithbuffer (black
circles; n 
 14) or Syn (0.5 and 5 M; red circles; n 
 16). Dotted lines represent regression fits for buffer-treated (black) and Syn-treated (red) neurons. C, Left, Superimposed current
density–voltage curves showing IBa (P1; black circles) and effect of a depolarizing prepulse to120mV (P2; black squares) in control SCGNs used inA. Right, Superimposed current density–voltage
curves showing IBa (P1; red circles) and effect of a depolarizing prepulse to120 mV (P2; red squares) in 5M Syn-treated SCGNs used in A. Middle, Bar chart summarizing the facilitation ratio
(P2/P1) expressed as themean SEM in control (black) and5MSyn-treated (red) SCGNs. ctrl, Control; PP, prepulse.D, Left, EPSPamplitude evokedat 0.1Hz in SCGN synapses. At t
0min, buffer
(black circles;n
4) or Syn (red circles;n
6)weredrop applied to the2mlbath (5M final concentration). EPSPamplitudewasnormalized to that before protein bath application for eachneuron.
Thepinkandgray lines represent smoothedvalues (10-pointmoving-averagealgorithm)of the EPSPamplitudes. Right, Top, RepresentativeAPandEPSP tracesmeasuredat 40min in control (black)
and Syn-treated (red) SCGNs. Right, Bottom, Bar chart showing the increase of the normalized EPSP amplitude expressed as the mean SEM at t
 40min in control (black) or Syn-treated (red)
SCGNs. Statistical significance determined by nonparametric t test. *p 0.05.
Table 1. Effects of Syn on IBa current density
I–V Current density at 0 mV (pA/pF) Gmax (nS/pF) Vrev (mV) n
Ctrl 19.6 2.0 0.33 0.03 54.4 3.4 8
Syn 5M 33.5 2.6* 0.56 0.04* 61.5 2.3 10
Ctrl 18.4 2.6 0.31 0.04 54.6 2.3 6
Syn 0.5M 37.6 3.9* 0.63 0.07* 52.3 1.5 6
Ctrl 19.0 7.1 0.32 0.12 51.4 1.3 6
Syn 0.1M 19.1 8.5 0.32 0.14 53.6 1.0 5
Current densities from control and Syn-treated SCG neurons were plotted against voltage and fitted with a single
Boltzmann function. *p0.05 versus control (Ctrl). Statistical significance for I–Vdata, expressed asmean SEM,
was determined by Student’s t test.
Table 2. Effect of 5M Syn on IBa parameters
Tail currents k (mV) V0.5 (mV) A1 n
Ctrl 12.1 0.5 4.7 2.0 0.98 0.02 8
Syn 5M 8.0 1.3* 0.2 2.5 0.96 0.02 10
Tail currents from control and Syn-treated SCGNs were plotted against voltage and fitted with a single Boltzmann
function, as shownby single amplitude (A1) component values close to 1. *p 0.05 versus control (Ctrl). Datawere
expressed as mean SEM. Statistical significance was determined by nonparametric Mann–Whitney U test.
Table 3. Effects of PPF on Synmodulation of IBa current density
I–V Current density at 0 mV (pA/pF) Vrev (mV) n
Ctrl 19.6 2.0 54.4 3.4 8
Ctrl PP 29.6 3.5* 51.8 2.4
Syn 5M 33.5 2.6* 61.5 2.3 10
Syn 5M PP 43.0 3.1**,*** 58.5 1.0
Ctrl 18.4 2.6 54.6 2.3 6
Ctrl PP 21.0 2.4* 54.7 2.7
Syn 0.5M 37.6 3.9* 52.3 1.5 6
Syn 0.5M PP 43.1 5.6**,*** 52.2 1.1
Ctrl 19.0 7.1 51.4 1.3 6
Ctrl PP 22.1 7.9* 52.5 1.2
Syn 0.1M 19.1 8.5 53.6 1.0 5
Syn 0.1M PP 23.0 9.1*** 53.7 1.1
Current densities from control and SCGNswere plotted against voltage and fittedwith a single Boltzmann function;
prepulse (PP; to120 mV). *p 0.05 versus control Ctrl); **p 0.05 versus control PP; ***p 0.05 versus
Syn. Data were expressed as mean SEM. Statistical significance determined by Student’s t test.
10608 • J. Neurosci., August 6, 2014 • 34(32):10603–10615 Ronzitti et al. •-Synuclein Affects Cav2.2 Channel Function
at 0 mV, showing that PPF of IBa caused a similar level of current
relief from basal G-protein inhibition compared with controls
(Fig. 3C, middle inset). Thus, together with the above, acutely
isolated SCGNs exhibit enhanced calcium currents when pre-
treated with Syn, but Syn effects cannot be explained by a change
in channel sensitivity to G-protein modulation.
We next investigated the modulatory role of Syn in synaptic
transmission, taking advantage of the synapses formed among
SCGNs in long-term culture (Fig. 3D). This is awell characterized
model for studying fast cholinergic transmission andmodulation
of Cav2.2 (Mochida et al., 2003; Stephens and Mochida, 2005).
Incubation of neurons with 5M Syn caused an increase in EPSP
amplitude (Fig. 3D, left), with the maximum increase reached
	40min after Syn application. The increase in synaptic transmis-
sion was reversible; washing out Syn from the bath returned syn-
aptic transmission to control levels after an additional 40 min.
These results indicate that Syn plays a modulatory role in evoked
synchronous transmitter release, leading to an	33% increase in
EPSP amplitude compared with control (Fig. 3D, right). The
observed effect of Syn on synaptic transmission is consistent with
the reported increase in calcium current through presynaptic
Cav2.2.
Syn-dependent activation of Cav2.2 leads to increased DA
release in the striatum
Little is known about synaptic dysfunctions at the premanifest
stage of PD. In mice overexpressing Syn, tonic DA release is in-
creased at early stages of the pathology (Lam et al., 2011), and we
show that Syn-dependent activation of Cav2.2 at the presynapse
leads to altered neurotransmitter release in SCGNs. Increased
extracellular DA may be a common mechanism contributing to
substantia nigra dopaminergic neuron stress and eventual de-
mise, subsequently leading to downregulation of synaptic activity
in the striatum. To assess the effect of extracellular Syn on DA
release in the striatum, we performed fast scan cyclic voltamme-
try experiments on striatal slices perfusedwith 5Mpurified Syn.
Axonal DA release in the dorsolateral striatum was evoked using
a twisted bipolar stimulating electrode. Stimulations were deliv-
ered every 2 min by a single electrical pulse (1 ms, 400 A). Syn
dissolved in aCSF was superfused 10 min after the first measure
(control period), and, after 20 min of treatment, DA release in-
creased by 	30% (Fig. 4A), in agreement with the observed in-
crease in EPSP amplitude (Fig. 3D). Similarly to that observed for
calcium entry, superfusion with -conotoxin primarily ablated
DA release (Fig. 4A). -Conotoxin also reduced basal DA levels
by	60%, indicating that, in dorsolateral striatum preparations,
Cav2.2 are the predominant calcium channels supporting neu-
rotransmission (Phillips and Stamford, 2000). The large increase
inDA release induced by excess Syn suggested a physiological role
for Syn in the regulation of neurotransmitter release in the stria-
tum. We wondered whether sequestration of constitutively re-
leased Syn from neurons would modify DA release in the
opposite way. Perfusion of slices with anti-Syn antibody induced
a significant 	10% decrease in DA release (Fig. 4B), indicating
that Syn, in physiological conditions, acts as a positive regulator
of neurotransmission.
To investigate the effect of in vivo acute administration of
Syn on the release of DA in the striatum, we performed micro-
dialysis to perfuse Syn in the striatum and measured DA re-
leased from the same area (Fig. 4C). The ability of Syn to
diffuse through a microdialysis membrane with 100 kDa cut-
off was determined under in vitro microdialysis conditions,
and the passage of Syn into the solution outside the membrane
was verified by immunoblot (Fig. 4C, top). Then, a 4-mm-
long microdialysis cannula passing through the whole length
of striatum was placed in the dorsal striatum of the rat. Freely
moving rats were perfused at a rate of 0.25 l/min with aCSF
Figure 4. Syn increases DA release ex vivo and in vivo. A, Fast-scan cyclic voltammograms of
evoked DA release from striatal brain slices. Data were acquired every 2 min. At t
 10 min,
buffer or 5M Syn was superfused. At t
 30 min, 25 nM-conotoxin was superfused for the
remaining 20min. Top, Representative voltammogram identifying the analyte as DA (left) and
the amplitude of DA traces obtained during buffer (black) and Syn (red) superfusion (right).
Bottom, Quantification of currents in control (black; n
 2) and Syn-treated (red; n
 4) slices
before any addition (pre), during buffer or Syn treatment (post), and during -conotoxin
(cono) treatment. Currents were normalized to the current in the first 10 min for each sample.
Data were expressed as mean SEM. B, Quantification of currents during the 10 min before
any addition (pre) and during 10 min of treatment without or with 4g of anti-Syn antibody
(Syn Ab) (post) in control (black; n
 3) and antibody perfused (red striped; n
 3) slices.
Currentswerenormalized to the current in the first 10min for each sample.Datawereexpressed
asmeanSEM. InAandB, statistical significancewasdeterminedby two-wayANOVA for each
condition.*p 0.05. C, Top, Immunoblot showing the diffusion of Syn across themicrodialysis
membrane under in vitro conditions. Syn at 10M (IN)was added to the perfusion solution and
perfused via a microdialysis cannula; samples of the external solution were collected at the
indicated times. Bottom, Quantification of releasedDAmeasured by in vivomicrodialysis in four
awake animals during hour 3 of perfusionwith buffer (black) or Syn (red). Datawere expressed
as percentage of DA level measured during perfusion with buffer, as mean SEM. Statistical
significance determined by nonparametric t test. *p 0.05.
Figure 5. Syn does not alter modulation of Cav2.2 by interaction with major binding pro-
teins. A, Immunoblot showing coimmunoprecipitation with anti-Cav2.2 antibody (Cav2.2 Ab)
from cortical neurons incubated with buffer ( Syn) or Syn ( Syn) for 2 h at 37°C. The left
three lanes show extracts (Input; 10% of the total). The right three lanes show immunoprecipi-
tates (IP).Western blottingwas performedwith the antibodies indicated on the right.B, Quan-
tification of calcium transients in cortical neurons incubated with buffer (black) or Syn (red) for
2 h at 37°C. At 30 min before imaging, neurons were incubated with DMSO () or 1 M
GF109203X (). Experimentswereperformedas in Figure 2A.n
100 for each condition. Data
are expressed as mean SEM of F/F0 normalized to the respective control. Statistical signifi-
cance determined by one-way ANOVA. *p 0.05. C, Immunoblot showing coimmunoprecipi-
tation with anti-Cav2.2 subunit antibody from cortical neurons incubated with buffer ( Syn)
or Syn ( Syn) for 2 h at 37°C, as described in A.D, Steady-state inactivation curves for control
(ctrl; black circles; n
 7) and 5M Syn-treated (red circles; n
 8) SCGNs.
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solution with or without 10 M Syn.
Samples were collected for 60 min dur-
ing hour 3 after addition of Syn into the
perfusion solution and measured by
HPLC. These experiments revealed a
significant	50% increase in DA release
in the Syn-treated group compared with
respective control values obtained dur-
ing perfusion of solution without Syn
(Fig. 4C, bottom).
Extracellular Syn does not affect Cav2.2
interaction with major regulatory
proteins
CaV2.2 function is widely reported to be
dictated by their interaction with a num-
ber of binding partners (Jarvis and Zam-
poni, 2007). Therefore, we investigated
whether Syn directly bindsCav2.2 to affect
their kinetics or indirectly affects other
regulatory proteins. Neurons, incubated
with 5 M Syn for 2 h, were lysed and im-
munoprecipitated with anti-Cav2.2 anti-
body. Syn band was present also in the
absence of anti-Cav2.2 antibody and in
the absence of Syn addition because of un-
specific binding of endogenous Syn to
agarose beads, but it was not significantly
increased in the anti-Cav2.2 Syn sample
(1.07 0.19-fold vs control in the absence
of Syn, n
 3), excluding a direct binding
between the two proteins (Fig. 5A). To
further evaluate the possibility that Cav2.2
activation was attributable to impaired
binding of G-protein 1 subunit to the
channel (Dolphin, 2003), we coimmuno-
precipitated with anti-Cav2.2 antibody.
The difference in the amount ofG-protein
1 subunit coimmunoprecipitated with
the channel in the presence of extracellu-
lar Syn was not significant (1.05  0.11-
fold vs control in the absence of Syn; n

3; Fig. 5A), a result that is consistent with
the observed lack of change in PPF in elec-
trophysiological experiments. Further-
more, Cav2.2 is activated by protein
kinase C (PKC; Stea et al., 1995), but in
the presence of the PKC inhibitor
GF109203X (2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-
indol-3-yl)maleimide) (Fig. 5B), there was no change in
Syn-dependent increase in -conotoxin-sensitive calcium entry,
excluding PKC as a mediator of Syn effect. To evaluate the pos-
sibility that Syn could induce a change in the binding of syntaxin
1A to Cav2.2 and remove the tonic inhibition of the channel
(Davies et al., 2011), we analyzed the interaction between the two
proteins in the absence or presence of Syn. No differences were
observed between control and Syn-treated samples (1.03 0.26-
fold vs control in the absence of Syn; n
 3; Fig. 5C). Syntaxin 1A
modulation of CaV2.2 has been reported to be associated with a
stabilization of channel inactivation (Bezprozvanny et al., 1995).
Consistent with a lack of effect on syntaxin 1A binding, Syn had
no effect on CaV2.2 voltage dependence of inactivation (Fig. 5D).
Together, these data suggest that Syn neither binds directly to
CaV2.2 nor acts by disrupting binding of effectors of major path-
ways incident on CaV2.2.
Extracellular Syn decreases plasmamembrane
cholesterol content
Ion channel activity is also widely reported to be regulated via the
cholesterol content of the plasma membrane (Levitan et al.,
2010), with calcium current shown to be decreased by cholesterol
loading (Jennings et al., 1999; Toselli et al., 2005). Therefore, we
measured total and plasma membrane cholesterol by staining
with filipin, a cholesterol bindingmolecule, in permeabilized and
nonpermeabilized neurons, respectively (Fig. 6A). Although
methyl--cyclodextrin (MCD), as expected, depleted both total
Figure 6. Syn acts on the content of plasmamembrane cholesterol that affects calcium channel activation and neurotransmit-
ter release. A, Bar chart showing cholesterol levels determined by quantitative fluorescent filipin staining. Cortical neurons incu-
bated with buffer (black), 1 mM MCD (gray) or 5M Syn for 2 h (red), fixed and stained with filipin, with (left; total) or without
(right;membrane) 0.1%Triton X-100. Bound filipinwas extracted and quantified in a fluorometer.Mean fluorescence values from
three different experiments each normalized to the respective controls.B, Bar chart showing calcium transients in cortical neurons
incubated with buffer (black), MCD (green), or 5M Syn for 2 h (red). Experiments were performed as in Figure 2A. Data were
expressed as normalized F/F0 values. C, Bar chart showing filipin fluorescence of cortical neurons incubated with buffer (black) or
Syn (red) in thepresence or absence of 1.3mg/ml chol-MCD for 2h at 37°C. Neuronswere fixed and stained as inA, in the absence
of detergents (membrane). D, Bar chart showing calcium transients in cortical neurons incubated with buffer (black) or Syn (red)
in the presence or absence of chol-MCD. Experiments were performed as in Figure 2A. In A and C, n
 12 for each condition; in
BandD,n
150 for each condition.Datawere expressedasmeanSEM. Statistical significancedeterminedbyone-wayANOVA.
*p 0.05. E, Bar chart showing decrease of the EPSP amplitude normalized to the first 20min before cholesterol addition (black),
in chol-MCD-treated SCGN synapses at t
 10min (gray, at the concentrations indicated). F, Left, Amplitude of EPSPs evoked at
a frequency of 0.1 Hz in SCGN synapses. At t
 0min, 5M Syn and chol-MCD at 0.13mg/ml (red dots; n
 3) were applied as
in Figure 3D. EPSPs amplitudewas normalized to the amplitude before protein bath application. Right, Bar chart showing the EPSP
amplitude normalized to the first 20min before any addition (black) in SCGN synapses treatedwith chol-MCD and Syn (red/gray
striped; n
 3) at t
 10 min and at t
 30 min. In E and F, data were expressed as the mean SEM. Statistical significance
determined by one-way ANOVA. *p 0.05. ctrl, Control.
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and membrane cholesterol, Syn induced a selective 	30% de-
crease in plasma membrane cholesterol (Fig. 6A, right), whereas
total cholesterol was unchanged. To assess the role of cholesterol
on calcium influx in isolated cells, we used MCD and
cholesterol-loaded MCD (chol-MCD) to decrease and in-
crease cholesterol content, respectively. We found that KCl-
evoked calcium entry in the absence of calcium channel
inhibitors was increased by MCD, an effect mimicked by Syn
(Fig. 6B), whereas in neurons loaded with cholesterol, evoked
calcium entry was less than half of that in controls (Fig. 6D). We
next investigated whether cholesterol loading of neurons could
prevent Syn-induced depletion of plasma membrane cholesterol
and calcium increase; indeed, both effects were blocked when
neurons were incubated with chol-MCD and Syn together (Fig.
6C,D). Together, these results indicate
that a decrease in plasma membrane cho-
lesterol content induced by extracellular
Syn is causal to the increase in intracellu-
lar calcium. We next wondered whether
cholesterol loadingwould act in the oppo-
site manner to Syn and act to inhibit neu-
rotransmitter release. SCGNs treated with
0.13 and 1.3mg/ml chol-MCD showed a
dramatic reduction in EPSP amplitude
comparedwith control (Fig. 6E). Tomon-
itor in real time the possible effect of cho-
lesterol loading on Syn-driven increase in
EPSP (Fig. 3D), we recorded EPSP from
SCGNs loaded with chol-MCD in the
presence of Syn (Fig. 6F). The initial in-
crease in amplitude was almost com-
pletely reversed after 20 min, with the
effect of Syn decreasing to 40% of the ini-
tial value after 30 min. During washout,
the reduction of EPSP amplitude per-
sisted for the duration of the recording
time (100min; Fig. 6F), indicating that cho-
lesterol loading strongly attenuated Syn ef-
fect on neurotransmission. Together, these
results suggest a causal role for cholesterol in
mediating Syn action.
Cav2.2 at the plasmamembrane
relocalize into cholesterol-poor
domains during Syn action
An increased activity of Cav2.2 could be
attributable to an increase in their surface
expression. We characterized the amount
of Cav2.2 by cell-surface biotinylation and
found that Syn does not affect Cav2.2 ex-
pression at the neuronal plasma mem-
brane (1.17  0.10-fold vs control in the
absence of Syn; n 
 4; Fig. 7A). The re-
duced cholesterol level in the plasma
membrane of neurons exposed to Syn was
suggestive of a change in microdomain
composition and partitioning of proteins.
To address this hypothesis, we analyzed
the potential changes in raft partitioning
of different proteins in response to Syn
treatment. Neuronal extracts were loaded
at the bottom of a nonlinear sucrose gra-
dient (Fig. 7B) and were shown to contain the same protein and
cholesterol content in each fraction between control and Syn-
treated neurons (Fig. 7C). It is well established that proteins, such
as flotillin-1 and caveolin, represent markers for lipid rafts and
partition into Triton X-100-insoluble cholesterol-rich microdo-
mains (Bickel et al., 1997). In our gradient, flotillin-1 and caveo-
lin were recovered in fractions 5 and 6 (Fig. 7D). Proteins that do
not reside in cholesterol-rich domains, such as Na/K ATPase and
Hsp90, are solubilized by Triton X-100 andwere recovered in the
non-flotating bottom fractions of the gradient (fractions 9 and
10; Fig. 7D). We found no significant differences in the distribu-
tion of the proteins analyzed in Figure 7D; however, during Syn
incubation of neurons, Cav2.2 protein residing in the raft do-
mains was decreased and its concentration was increased in the
Figure 7. Separation of proteins by sucrose gradient. A, Cell-surface biotinylation of cortical neurons incubated with buffer
( Syn) or Syn ( Syn) for 2 h. The left three lanes show extracts (Input; 10% of the total). The right three lanes show nonbioti-
nylated ( biotin) and biotinylated ( biotin) proteins pulled down with streptavidin beads. Western blotting was performed
with the antibodies indicated on the right. B, Schematic diagram of sucrose gradient fractionation. Cell extracts in 40% sucrose
were placed at the bottom of the centrifuge tube and overlaid with 30% and 5% sucrose solutions. C, Quantification of the
cholesterol and protein content in the fractions collected from the gradient loaded with cortical neuron extracts incubated with
buffer (black dots; n
 3) or Syn (red dots; n
 3) for 2 h. Data were expressed as percentage of the total cholesterol or protein
content calculated as the sum of the content in each fraction. D, Representative immunoblot of sucrose gradients loaded with
extracts derived fromneurons incubatedwith buffer (ctrl) or Syn (Syn), showing the distribution of proteins in raft (fractions 5 and
6; flotillin-1, caveolin, G-protein1,21 subunit), flotating non-raft (fractions 7 and 8; synaptophysin, rab11, G-protein1),
and cholesterol-poormembranes (fractions 9 and 10; Na/K ATPase, Hsp90, Cav1.2). E, Top, Sucrose gradient separation of proteins
in lipid raft (5 and 6), flotating non-raft (7 and 8), and 1% Triton X-100 solubilized (9 and 10) components from cortical neurons
incubatedwith buffer (ctrl) or Syn (Syn) for 2 h.Western blottingwas performedwith anti-Cav2.2 subunit. Bottom, Quantification
by densitometry of protein content in the indicated fractions described above (n
 3). Data were expressed as percentage of the
total protein amount calculated by the sum of the content of the protein of interest in each fraction. Statistical significance
determined by paired t test. *p 0.05. F, Immunoblot of sucrose gradients loadedwith extracts derived from neurons incubated
without (ctrl) or with 1.3 mg/ml MCD, showing the distribution of proteins in raft, as described in D.
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fraction containing solubilized proteins (Fig. 7E). As a control for
cholesterol depletion, we treated neurons with MCD and then
loaded extracts on a sucrose gradient (Fig. 7F). However, MCD
primarily depletes cholesterol both inside the cell and at the
membrane (Fig. 6A) and, as expected, induced an almost com-
plete solubilization of Cav2.2 and also of proteins tightly associ-
ated with lipid rafts, such as flotillin-1.
Finally, we examined the behavior of surface exposed
Cav2.2, whose activity accounted for the increased calcium
currents observed in the presence of Syn above. We found that
	40% of the biotinylated channels that were in rafts in control
conditions shifted to cholesterol-poor domains of the plasma
membrane during Syn incubation (Fig. 8A, left); in contrast,
2-1 subunits, which also partition in lipid rafts and are
widely reported tomodulate trafficking and to direct Cav2 into
lipid rafts (Davies et al., 2006; Robinson et al., 2010), remained
in cholesterol-rich domains (Fig. 8A, right). These data indi-
cate that the presence of extracellular Syn cause a relocation of
cell-surface Cav2.2 into cholesterol-poor domains of the
plasma membrane (Fig. 8B). This change in the environment
of the channel is consistent with increased channel activation,
calcium entry, and release of neurotransmitters.
Discussion
Our study focuses on the pathological role of increased concen-
trations of extracellular Syn, a condition that might arise by the
release of Syn from neurons in which Syn is overexpressed, be-
cause of the presence of multiple SNCA gene copies (Singleton et
al., 2003; Farrer et al., 2004) or polymorphism in regions of the
gene that regulate its expression (Chiba-Falek et al., 2006). Our
results provide evidence that Syn alters the organization of the
plasmamembrane of neurons, acting on the external leaflet of the
membrane to lower the content of plasmamembrane cholesterol
and thereby altering the partitioning of surface-associated pro-
teins. Syn action leads to increased presynaptic calcium influx
and neurotransmitter release mediated by CaV2.2. There is much
evidence that Syn function is related to its association with
plasma and vesicularmembranes at synaptic terminals (Sharon et
al., 2001) and in particular with lipid rafts (Fortin et al., 2004). In
vitro studies suggest an effect of Syn on the integrity of lipid
bilayers inducing lipid clustering (Madine et al., 2006). It was
shown recently in SH-SY5Y cells that membrane fluidity was
affected by exogenous Syn (Melachroinou et al., 2013). The ob-
served effect of Syn on the composition of plasma membrane
may involve altered endocytosis or recycling of lipid andproteins,
leading to incorrect positioning of proteins in microdomains
with different lipid composition, rather than causing differences
in the amount of proteins at the cell surface. In our study, an
effect of Syn on membrane retrieval to the intracellular com-
partment was ruled out by the measurements of capacitance,
which appeared unchanged. However, it is possible that mem-
brane retrieval of raft domains is accompanied by recycling of
cholesterol-poor vesicles at the membrane, leaving the surface
area intact. In particular, we found that Cav2.2 repositioned in
cholesterol-poor domains with important effects on channel
electrophysiological properties. The reported reduction in slope
factor from calcium tail current amplitude measurements sug-
gests an improvement of channel voltage sensitivity, such that the
gating charges move more easily and, thus, that channel activa-
tion is improved. The large increase in current conductance with
an accompanying improved voltage sensitivity of the channel is
likely a result of the compartmentalization of the channel in less
stiffer membrane domains in which the membrane deformation
energy required for the transition from closed to open state is
lower (Lundbaek et al., 1996; Levitan et al., 2000). It has been
shown that lipid rafts composition affects calcium channels cur-
rents (Davies et al., 2006; Levitan et al., 2010). In neuroblas-
toma  glioma NG-108 hybrid cells, cholesterol loading
selectively reduces Cav2.2 currents by decreasing the channel
open probability (Toselli et al., 2005). Conversely, cholesterol
depletion by MCD, which disrupts lipid rafts, has been shown
to induce increase CaV2.1 current in recombinant cells (Davies et
al., 2006) and to cause a trend to increase current in caveolin-1
transfected NG-108 cells (Toselli et al., 2005). These reports sug-
gest that association of CaV2.2 in a lipid-rich environment results
in reduced calcium current, whereas in a lower cholesterol envi-
ronment, current is increased. Here we show that, in both central
and peripheral neurons, cholesterol depletion mimics Syn action
and that cholesterol loading has opposite effects to Syn on syn-
aptic transmission. The improved transition between the closed
and open states of the channels in a cholesterol-poor environ-
ment seems independent of the association of the channel with
2-1 subunit on the surface. Thus, the localization of surface
2-1 subunit, highly enriched in raft domains (Robinson et al.,
2010), was unaffected by the presence of Syn. 2 subunits con-
trol the functional expression of the 1 subunit, modulating its
trafficking from the cell somaand leading to a significant increase in
synaptic abundance of 1 (Dolphin, 2009). The comparable
amount of surface-exposed Cav2.2 in control and Syn-treated neu-
rons indicated that 2-1-dependent trafficking of channels to the
membrane was unchanged. Overall, we demonstrate that the Syn-
mediated shift of Cav2.2 into cholesterol-poor domains is sufficient
to induce enhancement of calcium current independently of 2
association with the channel.
Our data suggest that, in the presence of Syn, channels are
shifted into a low-cholesterol environment, and the ensuing in-
crease in calcium influx has a profound effect on release. It has
Figure 8. Syn induces relocalization of surface-exposed Cav2.2 in cholesterol-poor areas. A,
Cell-surface biotinylation followed by sucrose gradient separation of fractions as described in
Figure 7E, from cortical neurons incubated with buffer (ctrl) or Syn (Syn) for 2 h. Western
blottingwas performedwith anti-Cav2.2 subunit (left) and anti-21 subunit (right) antibod-
ies. Bottom, Quantification by densitometry of protein content in the indicated fractions (as in
Fig. 7E) collected from the gradient (n
 3). Statistical significance determined by paired t test.
*p 0.05. B, Diagram showing the partition of Cav 2.2 (green) that, in the presence of extra-
cellular Syn, relocate into cholesterol (red)-poor domains of the plasma membrane, whereas
21 subunit (blue) remains in raft domains. The relocalization of Cav 2.2 correlates with
increased channel activity (double black arrows).
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been shown that cholesterol depletion does not influence the
confinement of Cav1 in proximity to release sites at bipolar cells
ribbon synapses (Thoreson et al., 2013), suggesting that lipid rafts
are not required to cluster Cav1, but rather clusters of channels
are maintained by interaction with presynaptic proteins and cy-
toskeletal elements. Effects may be synapse specific, in that the
same group reports that cholesterol depletion does affect Cav1
channel mobility at photoreceptor synapses in the retina (Mercer
et al., 2011, 2012). Importantly, in these studies, Cav1 channel
mobility was assessed via the use of antibodies against the major
retinal 2-4 subunit. It may be that 2 subunits are important
for trafficking of Cav2.2 from the endoplasmic reticulum to the
plasma membrane (Dolphin, 2012), but once at the membrane,
association is more labile, consistent with reported low-affinity
association of 2 with Cav2.2 in plasma membrane proteomic
studies (Muller et al., 2010). As above, our data strongly suggest
that Syn effects on release occur in the absence of movement of
2-1, whichwe show to be retained in cholesterol-rich domains.
Therefore, it is possible that, during exposure to Syn, Cav2.2,
independently from 2-1 and lipid rafts, remain positioned at
lower cholesterol regions within active zones in which they sus-
tain neurotransmitter release. It is also reported that cholesterol
depletion decreases synaptic vesicles release by altering mem-
brane curvature (Rituper et al., 2013). However, extracellular Syn
did not affect internal cholesterol levels here, arguing against a
major contribution to effects on release in this study. Another
possible explanation for the observed increase inCav2.2 activity is
that changes in membrane organization may move the channels
into proximity of a second messenger, such as phosphatidylino-
sitol 4,5-bisphosphate, which in turn modulates channel activity
(Roberts-Crowley et al., 2009). The importance of Cav2.2 in neu-
rotransmission at the presynapse is well documented, and these
channels are the main players in the control of striatal DA release
(Phillips and Stamford, 2000). We provide evidence that DA re-
lease is significantly increased in a-conotoxin-sensitivemanner
in striatal slices superfused with Syn, and this result correlates
with the increase in calcium entry at the presynapse, as assessed
by the use of SyGCaMP3. Together, these data identify a mecha-
nism that would explain the increase in DA release found at pre-
manifest stages of PD in Syn transgenic mice (Lam et al., 2011)
and in virus-injectedmice at early stages of the pathology (Chung
et al., 2009). The increase in DA is reproduced in vivo by micro-
dialysis of Syn directly into the striatum, suggesting a tonic in-
crease in DA levels attributable to Syn accumulation in the
synaptic cleft. Early alterations at the synaptic terminals level
might be responsible for the “dying back” of dopaminergic neu-
rons starting at the axon terminal, sensitizing DA neurons in the
initial, presymptomatic, stages of disease. The underlying regula-
tory mechanism we propose—Syn-mediated disorganization of
lipid rafts (Fig. 8B)—may also occur in other areas prone to
neurodegeneration in PD and affect the function of other plasma
membrane-associated proteins, possibly explaining the selective
vulnerability of particular subset of neurons depending on their
lipid and protein composition. As an example, the Cav2.2 knock-
out mice model displays reduction in pain sensitivity (Saegusa et
al., 2002), and pain is one of the non-motor symptoms of PD;
therefore, we can speculate a causal relationship between hyper-
activation of Cav2.2 and pain sensitivity in PD.
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